We constructed a 10-gene risk model (PFKFB4, P4HB, OR2B6, OCIAD2, OAS1, KCNJ15, AHNAK, RAC3, EMP1, and PRKY) associated with the prognosis of BLCA patients. This evidence concerns the gene OR2B6 and bladder transitional cell carcinoma.